New findings from the DIGIT-HF trial show low-dose digitoxin can reduce the risk for hospitalization and all-cause mortality in patients with symptomatic heart failure. The results, presented at the ...

MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...

Digitoxin reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and a reduced ejection fraction (HFrEF), according to ...

MADRID -- Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed. The cardiac ...

Madrid, Spain – 29 August 2025: Digitoxin reduced the risk of a composite of all-cause death and hospitalisation for worsening heart failure (HF) among patients with advanced HF and a reduced ejection ...

Treatment with digitoxin led to a lower combined risk of death from any cause or hospital admission for worsening heart failure than placebo among patients with heart failure and reduced ejection ...

Please provide your email address to receive an email when new articles are posted on . Digitoxin reduced risk for death or worsening heart failure vs. placebo in patients with heart failure with ...

Digitalis has been used to treat heart failure for more than 200 years. The drug digitoxin also belongs to this group of active ingredients known as cardiac glycosides. Although there were indications ...

As in years past, heart failure (HF) continues to be one of cardiology’s most exciting areas when it comes to the development of new therapies and innovations for patient care. The year saw the ...

Latest prescription information about Digitoxin. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its ...